Theorem Clinical Research Expands Partnership with Medidata Solutions

Theorem Clinical Research Expands Partnership with Medidata Solutions

(King of Prussia, PA; April 17, 2014) – Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud™.

This accreditation enables Theorem to provide a unified approach to capture data directly from patients. Clinical investigators and sponsors will gain operational efficiencies with immediate access to review electronic patient reported outcomes (ePRO) data in one platform while leveraging Theorem's clinical expertise.

"We will be able to transform what can be a lengthy and expensive process into a fast implementation using Medidata's platform of cloud-based solutions, which includes capabilities to facilitate direct communication with patients," said Mark Penniston, executive vice president and general manager for clinical analytics.           

"Theorem shares our vision of bringing the voice of the patient into clinical research and positively transforming the clinical trial experience for all study participants," said Steve Heath, Medidata's vice president of channel sales. "This accreditation reinforces Theorem's commitment to leveraging innovative technology to accelerate the delivery of medicine to patients around the world."

Theorem has built hundreds of studies in Medidata Rave® and is a top holder of accreditations among Medidata Services Partners with accreditation in:

·         Medidata Rave®

·         Medidata Rave® Safety Gateway

·         Medidata Rave® Targeted SDV

·         Medidata Balance Randomization®

Theorem clinical analytics experts will deliver two presentations during the Medidata Symposium 2014 April 23–25 in San Francisco:

·         Impact Analysis – Key Considerations Before Making Post-Production Changes, presented by April Bebee and Beatrice Clark

·         Targeted SDV (TSDV) Lessons Learned, presented by Vicken Yanikian

Additionally, innovative solutions will be featured during the symposium in the Innovation Lounge, including automation of mapping from Medidata Rave® into CDISC-compliant data sets via SAS CDI and real-time data visualizations from Medidata Rave® to Spotfire® visual analytics.

About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a broad range of therapeutic areas and in all phases of development. With some of the industry's top scientists and most advanced clinical analytics capabilities, Theorem ensures smooth-running, successful trials. For the full-service, right-size global research partner, don't think twice. THINK THEOREM.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

CONTACT:

Lea Studer

SCORR Marketing

308.237.5567

[email protected]

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.